Recruiting

Linkage-to-Care

Sponsor:

UCLA

Code:

NCT06943599

Conditions

Age Related Macular Degeneration

Diabetic Retinopathy

Glaucoma

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

Text Message Reminder

Health Worker Visit

Study Details

Brief summary:

The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.

Conditions

Age Related Macular Degeneration

Diabetic Retinopathy

Glaucoma

Study ID

NCT06943599

Start date

Feb 1, 2026

Status verified date

Apr, 2026

Completion date

Jun 30, 2028

Anticipated

Primary completion date

Jun 30, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Inclusion Criteria:

\- Participant of the VIEW II study referred to the eye hospital at their eye screening visit.

Exclusion Criteria:

  • Residence in an area without reliable mobile connectivity

Study Design

Enrollment

3000 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Text Message Reminders

experimental: Health Worker

no intervention: No Intervention

Interventions

Text Message Reminder

Participants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit.

Health Worker Visit

Participants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit.

Primary outcome measure

  • Referral Visit Attendance [ Time Frame: 21 days after screening ]

Central Contacts and Locations

Central contacts

Jeremy Keenan, MD, MPH

(415) 476-1442jeremy.keenan@ucsf.edu

Krisianne Aromin

krisianne.aromin@ucsf.edu

Locations

University of California, San Francisco

Recruiting

San Francisco, California, United States, 94158

More Information

Sponsor

University of California, San Francisco

Last update posted

Apr 29, 2026

Last verified

Apr, 2026

Keywords

  • Eye Diseases
  • mass screening
  • patient compliance
  • retention in care

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-04-29.